# Ulcerative Colitis Endoscopic Index of Severity and Fecal Calprotectin to Predict the Reaction to Corticosteroids of Acute Severe Ulcerative Colitis

> **NCT02922374** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Jinling Hospital, China** · enrollment: 117 (actual)

## Conditions studied

- Acute Severe Colitis (ASC)

## Interventions

- **DRUG:** corticosteroids

## Key facts

- **NCT ID:** NCT02922374
- **Lead sponsor:** Jinling Hospital, China
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-01
- **Primary completion:** 2016-06
- **Final completion:** 2016-12
- **Target enrollment:** 117 (ACTUAL)
- **Last updated:** 2016-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02922374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02922374, "Ulcerative Colitis Endoscopic Index of Severity and Fecal Calprotectin to Predict the Reaction to Corticosteroids of Acute Severe Ulcerative Colitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02922374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*